Pharmacogenetic determinants of anti-cancer drug activity and toxicity.
about
Epidemiology of lung cancer prognosis: quantity and quality of life.Gene expression levels as predictive markers of outcome in pancreatic cancer after gemcitabine-based adjuvant chemotherapy.Bioreductively activated antitumor N-oxides: the case of AQ4N, a unique approach to hypoxia-activated cancer chemotherapy.Pharmacogenomics for the treatment of dementia.Integration of molecular diagnostics with therapeutics: implications for drug discovery and patient care.Japanese single nucleotide polymorphism database for 267 possible drug-related genes.A tale of two approaches: complementary mechanisms of cytotoxic and targeted therapy resistance may inform next-generation cancer treatmentsEGF receptor-targeted therapy in non-small-cell lung cancer: role of germline polymorphisms in outcome and toxicity.Design, synthesis, characterization and DNA-binding studies of a triphenyltin(IV) complex of N-glycoside (GATPT), a sugar based apoptosis inducer: in vitro and in vivo assessment of induction of apoptosis by GATPT.
P2860
Q34135295-228F7CB5-C86B-42E5-9B10-1C9AFE3B5993Q34177223-D2C31CE1-6BE8-4279-8B47-24AF14408388Q34819107-F25F028F-FBD2-430B-9461-3B69C775A22BQ35009345-D44FA53A-5ABE-4540-A073-7550E8834DF1Q35016589-B0414B19-21BB-44D0-A8BA-61F6D8663785Q36347893-239519EA-184A-4C99-9663-08DBAA5C4001Q36740744-AB53EC6E-868D-49E4-A882-8AD51C0EA329Q38034817-6D5B0384-35BC-4AED-8999-B6250228564CQ39425495-E74CE835-973D-4B5A-99B1-5C5420DBF75F
P2860
Pharmacogenetic determinants of anti-cancer drug activity and toxicity.
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Pharmacogenetic determinants of anti-cancer drug activity and toxicity.
@ast
Pharmacogenetic determinants of anti-cancer drug activity and toxicity.
@en
Pharmacogenetic determinants of anti-cancer drug activity and toxicity.
@nl
type
label
Pharmacogenetic determinants of anti-cancer drug activity and toxicity.
@ast
Pharmacogenetic determinants of anti-cancer drug activity and toxicity.
@en
Pharmacogenetic determinants of anti-cancer drug activity and toxicity.
@nl
prefLabel
Pharmacogenetic determinants of anti-cancer drug activity and toxicity.
@ast
Pharmacogenetic determinants of anti-cancer drug activity and toxicity.
@en
Pharmacogenetic determinants of anti-cancer drug activity and toxicity.
@nl
P50
P1476
Pharmacogenetic determinants of anti-cancer drug activity and toxicity
@en
P2093
P304
P356
10.1016/S0165-6147(00)01742-9
P577
2001-08-01T00:00:00Z